THERAPEUTICSMD INC filings

SEC filings by THERAPEUTICSMD INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2019-12-10Bank of New York Mellon CorpTherapeuticsMD, Inc.13,389,8054.9%EDGAR
SC 13G/A2019-09-10Bank of New York Mellon CorpTherapeuticsMD, Inc.18,247,6197.6%EDGAR
SC 13G/A2019-02-14PRICE T ROWE ASSOCIATES INC /MD/TherapeuticsMD, Inc.21,522,3459.0%EDGAR
SC 13G/A2019-02-13FMR LLCTherapeuticsMD, Inc.18,088,3417.6%EDGAR
SC 13G/A2019-02-12VANGUARD GROUP INCTherapeuticsMD, Inc.13,295,4965.6%EDGAR
SC 13G/A2019-02-06BlackRock Inc.TherapeuticsMD, Inc.16,687,5637.0%EDGAR
SC 13G/A2019-01-29Bank of New York Mellon CorpTherapeuticsMD, Inc.31,451,35913.2%EDGAR
SC 13G/A2019-01-28FRANKLIN RESOURCES INCTherapeuticsMD, Inc.10,543,5884.4%EDGAR
SC 13G/A2019-01-28JPMORGAN CHASE & COTherapeuticsMD, Inc.19,836,6738.3%EDGAR
SC 13G/A2018-07-10PRICE T ROWE ASSOCIATES INC /MD/TherapeuticsMD, Inc.23,404,30910.8%EDGAR
SC 13G/A2018-06-11FMR LLCTherapeuticsMD, Inc.11,788,0535.4%EDGAR
SC 13D/A2018-04-16SMITH ROBERT JTherapeuticsMD, Inc.9,938,708-EDGAR
SC 13D/A2018-02-14SMITH ROBERT JTherapeuticsMD, Inc.12,959,108-EDGAR
SC 13G/A2018-02-14PRICE T ROWE ASSOCIATES INC /MD/TherapeuticsMD, Inc.17,431,3958.0%EDGAR
SC 13G/A2018-02-13FMR LLCTherapeuticsMD, Inc.23,068,84010.7%EDGAR
SC 13G2018-02-09VANGUARD GROUP INCTherapeuticsMD, Inc.11,403,8265.3%EDGAR
SC 13G/A2018-02-07Bank of New York Mellon CorpTherapeuticsMD, Inc.28,973,66813.4%EDGAR
SC 13G/A2018-02-05FRANKLIN RESOURCES INCTherapeuticsMD, Inc.10,992,4095.1%EDGAR
SC 13G/A2018-01-26JPMORGAN CHASE & COTherapeuticsMD, Inc.19,648,0129.0%EDGAR
SC 13G/A2018-01-23BlackRock Inc.TherapeuticsMD, Inc.14,431,8626.7%EDGAR